NEXA Stock Analysis: Nexa Resources | NYSE
Other Industrial Metals & Mining | NYSE, USA | Market Cap: 1.659m USD | 12M Return: 135.4% | LU1701428291 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 7.53M
Qual. Beats: 0
Rev. Trend: 86.8%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 8.9 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Nexa Resources S.A. (NYSE: NEXA) is a Luxembourg-domiciled company that operates a vertically integrated zinc mining and smelting business, with operations organized into two segments: Mining and Smelting. The company owns and operates five polymetallic mines (three in Peru and two in Brazil) along with three zinc smelters (one in Peru and two in Brazil), allowing it to extract ore and convert it into refined metal products.
Nexa produces metallic zinc, zamac, gold, sulfuric acid, and zinc oxide, alongside a range of by-products including silver concentrate, copper cement, copper sulfate, lead concentrate, and lead-silver concentrate. This polymetallic approach enables the company to generate revenue from multiple metals extracted and processed from the same ore bodies.
The company was founded in 1956, originally known as VM Holding S.A., and adopted its current name in September 2017 ahead of its October 2017 IPO. Nexa is a subsidiary of Votorantim S.A., a major Brazilian industrial conglomerate. It is classified within the Materials sector under the Diversified Metals & Mining sub-industry, reflecting its focus on base metals production. Zinc, the companys primary product, is primarily used for galvanizing steel to prevent corrosion, making demand closely tied to global construction and industrial activity.
- Zinc prices drive Mining segment revenue and margins
- Smelting profitability hinges on treatment charge negotiations
- Peru political risk threatens polymetallic mine output
| Net Income: 277.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 2.53 > 1.0 |
| NWC/Revenue: -8.65% < 20% (prev -3.10%; Δ -5.55% < -1%) |
| CFO/TA 0.11 > 3% & CFO 565.7m > Net Income 277.6m |
| Net Debt (1.60b) to EBITDA (1.20b): 1.33 < 3 |
| Current Ratio: 0.80 > 1.5 & < 3 |
| Outstanding Shares: last quarter (132.4m) vs 12m ago 0.0% < -2% |
| Gross Margin: 24.13% > 18% (prev 18.99%; Δ 5.14% > 0.5%) |
| Asset Turnover: 67.00% > 50% (prev 57.16%; Δ 9.84% > 0%) |
| Interest Coverage Ratio: 3.24 > 6 (EBIT TTM 834.7m / Interest Expense TTM 257.7m) |
| A: -0.06 (Total Current Assets 1.15b - Total Current Liabilities 1.45b) / Total Assets 5.38b |
| B: -0.18 (Retained Earnings -949.9m / Total Assets 5.38b) |
| C: 0.16 (EBIT TTM 834.7m / Avg Total Assets 5.13b) |
| D: 0.31 (Book Value of Equity 1.20b / Total Liabilities 3.87b) |
| Altman-Z'' = 0.48 = B |
| DSRI: 0.85 (Receivables 185.0m/175.8m, Revenue 3.44b/2.79b) |
| GMI: 0.79 (GM 18.99% / 24.13%) |
| AQI: 1.60 (AQ_t 0.29 / AQ_t-1 0.18) |
| SGI: 1.23 (Revenue 3.44b / 2.79b) |
| TATA: -0.05 (NI 277.6m - CFO 565.7m) / TA 5.38b) |
| Beneish M = -2.82 (Cap -4..+1) = A |
As of October 09, 2026, the stock is trading at USD 12.51 with a total of 349,600 shares traded. Over the past week, the price has changed by +6.02%, over one month by -11.40%, over three months by -1.79% and over the past year by +135.37%.
Current recommended Stop Loss: 11.50 (which is 8.1% or 1.7 ATR below the current price).
Nexa Resources has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold NEXA.
- StrongBuy: 0
- Buy: 0
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 14.8 | 18.6% |
P/E Trailing = 5.9952
P/E Forward = 3.4495
P/S = 0.4792
P/B = 1.4061
Revenue TTM = 3.44b USD
EBIT TTM = 834.7m USD
EBITDA TTM = 1.20b USD
Long Term Debt = 1.63b USD (from longTermDebt, last quarter)
Short Term Debt = 141.6m USD (from shortTermDebt, last quarter)
Debt = 1.99b USD (from shortLongTermDebtTotal, last quarter) + Leases 132.7m
Net Debt = 1.60b USD (calculated: Debt 1.99b - CCE 386.8m)
Enterprise Value = 3.26b USD (1.66b + Debt 1.99b - CCE 386.8m)
Interest Coverage Ratio = 3.24 (Ebit TTM 834.7m / Interest Expense TTM 257.7m)
EV/FCF = 18.82x (Enterprise Value 3.26b / FCF TTM 173.2m)
FCF Yield = 5.31% (FCF TTM 173.2m / Enterprise Value 3.26b)
FCF Margin = 5.04% (FCF TTM 173.2m / Revenue TTM 3.44b)
Net Margin = 8.08% (Net Income TTM 277.6m / Revenue TTM 3.44b)
Gross Margin = 24.13% ((Revenue TTM 3.44b - Cost of Revenue TTM 2.61b) / Revenue TTM)
Gross Margin QoQ = 25.31% (prev 30.64%)
Tobins Q-Ratio = 0.61 (Enterprise Value 3.26b / Total Assets 5.38b)
Interest Expense / Debt = 12.96% (Interest Expense 257.7m / Debt 1.99b)
Taxrate = 35.41% (217.6m / 614.7m)
NOPAT = 539.2m (EBIT 834.7m * (1 - 35.41%))
Current Ratio = 0.80 (Total Current Assets 1.15b / Total Current Liabilities 1.45b)
Debt / Equity = 1.65 (Debt 1.99b / totalStockholderEquity, last quarter 1.20b)
Debt / EBITDA = 1.33 (Net Debt 1.60b / EBITDA 1.20b)
Debt / FCF = 9.24 (Net Debt 1.60b / FCF TTM 173.2m)
Total Stockholder Equity = 1.08b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.41% (Net Income 277.6m / Total Assets 5.38b)
RoE = 25.68% (Net Income TTM 277.6m / Total Stockholder Equity 1.08b)
RoCE = 30.81% (EBIT 834.7m / Capital Employed (Equity 1.08b + L.T.Debt 1.63b))
RoIC = 13.83% (NOPAT 539.2m / Invested Capital 3.90b)
WACC = 10.06% (E(1.66b)/V(3.65b) * Re(12.09%) + D(1.99b)/V(3.65b) * Rd(12.96%) * (1-Tc(0.35)))
Discount Rate = 12.09% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 32.33 | Cagr: 0.0%
[DCF] Terminal Value 72.63% ; FCFF base≈117.4m ; Y1≈134.6m ; Y5≈198.0m
[DCF] Fair Price = 5.18 (EV 2.29b - Net Debt 1.60b = Equity 686.7m / Shares 132.4m; r=10.06% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.23 | # QB: 0
Revenue Correlation: 86.85 | Revenue CAGR: 9.51% | SUE: -0.03 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.56 | Chg30d=-1.47% | Revisions=+0% | Analysts=2
EPS current Year (2026-12-31): EPS=2.62 | Chg30d=+3.55% | Revisions=-17% | GrowthEPS=+208.6% | GrowthRev=+21.2%
EPS next Year (2027-12-31): EPS=3.20 | Chg30d=+3.68% | Revisions=-40% | GrowthEPS=+21.9% | GrowthRev=-0.9%
[Analyst] Revisions Ratio: -30% (up=2, down=5)